TP53 and myelodysplastic syndrome: A recent study showed that monoallelic TP53 mutations in patients with MDS are not independently predictive of inferior survival.41 Although we cannot exclude loss of heterozygosity in the other allele, we did not detect multiple mutations in TP53 in these individuals.